SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics

Ruirui Hu, Liwen Gao, Fei Hong, Xueying Li, Yuting Liu, Yun Yang

Open source

DOI
10.1016/j.leukres.2026.108360
Published
2026-12
Container
Leukemia Research
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.leukres.2026.108360,
  title = {SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics},
  author = {Ruirui Hu and Liwen Gao and Fei Hong and Xueying Li and Yuting Liu and Yun Yang},
  year = {2026},
  journal = {Leukemia Research},
  doi = {10.1016/j.leukres.2026.108360},
  url = {https://doi.org/10.1016/j.leukres.2026.108360}
}

RIS

TY  - JOUR
TI  - SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics
AU  - Ruirui Hu
AU  - Liwen Gao
AU  - Fei Hong
AU  - Xueying Li
AU  - Yuting Liu
AU  - Yun Yang
PY  - 2026
JO  - Leukemia Research
DO  - 10.1016/j.leukres.2026.108360
UR  - https://doi.org/10.1016/j.leukres.2026.108360
ER  - 

APA

Hu, R., Gao, L., Hong, F., Li, X., Liu, Y., & Yang, Y. (2026). SRSF2-mutated acute myeloid leukemia: Mechanisms, clonal evolution, prognostic reappraisal, and emerging precision therapeutics. Leukemia Research. https://doi.org/10.1016/j.leukres.2026.108360

Source records